tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Arvinas presents data from two Phase 1 trials for ARV-102
PremiumThe FlyArvinas presents data from two Phase 1 trials for ARV-102
13d ago
Amazon upgraded, Adobe downgraded: Wall Street’s top analyst calls
Premium
The Fly
Amazon upgraded, Adobe downgraded: Wall Street’s top analyst calls
24d ago
Arvinas downgraded to Neutral from Buy at BofA
Premium
The Fly
Arvinas downgraded to Neutral from Buy at BofA
25d ago
Arvinas price target lowered to $14 from $16 at Stephens
PremiumThe FlyArvinas price target lowered to $14 from $16 at Stephens
1M ago
Closing Bell Movers: Nucor slumps 5% after negative pre-announcement
Premium
The Fly
Closing Bell Movers: Nucor slumps 5% after negative pre-announcement
1M ago
Arvinas Announces 15% Workforce Reduction and Cost Savings
Premium
Company Announcements
Arvinas Announces 15% Workforce Reduction and Cost Savings
1M ago
Arvinas initiated with an Overweight at Barclays
PremiumThe FlyArvinas initiated with an Overweight at Barclays
1M ago
Arvinas and Pfizer’s FDA Nod for Cancer Drug
Premium
Company Announcements
Arvinas and Pfizer’s FDA Nod for Cancer Drug
2M ago
Arvinas, Pfizer announce FDA acceptance of vepdegestrant NDA
Premium
The Fly
Arvinas, Pfizer announce FDA acceptance of vepdegestrant NDA
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100